Furthermore, data pointing out that ghrelin, neurotensin, pituitary adenylate cyclase-activating polypeptide (PACAP), neuropeptide Y, substance P, and orexin may be associated with the pathophysiology and potential therapy of Alzheimer’s disease has been reviewed in [49]. The gene discussed is ADCYAP1; the disease is early-onset autosomal dominant Alzheimer disease.